{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:17:46Z","timestamp":1777537066979,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1124\/jpet.102.034702","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:44:00Z","timestamp":1042224240000},"page":"627-635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Roles of Substance P Receptors in Human Colon Circular Muscle: Alterations in Diverticular Disease"],"prefix":"10.1016","volume":"302","author":[{"given":"Lu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irit","family":"Markus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Burcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.034702_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/gast.2000.8552","article-title":"Gq-linked NK2 receptors mediate neurally induced contraction of human sigmoid circular smooth muscle.","volume":"119","author":"Cao","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.102.034702_bib2","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(98)00310-0","article-title":"Tachykinin NK1 receptor-mediated vasorelaxation in human pulmonary arteries.","volume":"350","author":"Corboz","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.034702_bib3","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.bjp.0701960","article-title":"In vitro characterisation of tachykinin NK2 receptor modulating motor responses of human colonic muscle strips.","volume":"124","author":"Croci","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.034702_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0026-895X(25)08831-5","article-title":"Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.","volume":"41","author":"Fong","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.102.034702_bib5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0196-9781(88)90184-2","article-title":"Substance P and substance K receptor binding sites in the human gastrointestinal tract: localization by autoradiography.","volume":"9","author":"Gates","year":"1989","journal-title":"Peptides"},{"key":"10.1124\/jpet.102.034702_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0026-895X(25)08817-0","article-title":"Radioiodinated substance P, neurokinin A and eledoisin bind predominantly to NK1 receptors in guinea pig lung.","volume":"41","author":"Geraghty","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.102.034702_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0014-2999(91)90892-T","article-title":"NK2 tachykinin receptors and contraction of circular muscle of the human colon; characterisation of the NK2 receptor subtype.","volume":"203","author":"Giuliani","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.034702_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/BF01540348","article-title":"Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation.","volume":"34","author":"Goldin","year":"1989","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.102.034702_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.47.3.387","article-title":"Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation.","volume":"47","author":"Goode","year":"2000","journal-title":"Gut"},{"key":"10.1124\/jpet.102.034702_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/CDLI.7.3.371-376.2000","article-title":"Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells.","volume":"7","author":"Goode","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1124\/jpet.102.034702_bib11","first-page":"G95","article-title":"Interaction between neurokinin A, VIP, prostanoids and enteric nerves in regulation of duodenal function.","volume":"275","author":"Hallgren","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.102.034702_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1357-2725(01)00031-0","article-title":"Substance P.","volume":"33","author":"Harrison","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1124\/jpet.102.034702_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3940(80)90069-5","article-title":"Neurally mediated contraction of ileal longitudinal muscle by substance P.","volume":"17","author":"Holzer","year":"1980","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.102.034702_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0163-7258(96)00195-7","article-title":"Tachykinins in the gut. Part I. Expression, release and motor function.","volume":"73","author":"Holzer","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.102.034702_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0163-7258(96)00196-9","article-title":"Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation.","volume":"73","author":"Holzer","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.102.034702_bib16","series-title":"Pharmacologic Analysis of Drug-Receptor Interaction.","author":"Kenakin","year":"1993"},{"key":"10.1124\/jpet.102.034702_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01296290","article-title":"Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.","volume":"32","author":"Koch","year":"1987","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.102.034702_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2982.1994.tb00179.x","article-title":"Effects of neurokinins on human colonic motility.","volume":"6","author":"K\u00f6lbel","year":"1994","journal-title":"Neurogastroenterol Mot"},{"key":"10.1124\/jpet.102.034702_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s004180050288","article-title":"Activation of neurokinin 1 receptors on interstitial cells of Cajal of the guinea-pig small intestine by substance P.","volume":"110","author":"Lavin","year":"1998","journal-title":"Histochem Cell Biol"},{"key":"10.1124\/jpet.102.034702_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1023\/A:1017943430627","article-title":"Neuropeptides and nerve growth in inflammatory bowel diseases: a quantitative immunohistochemical study.","volume":"47","author":"Lee","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.102.034702_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-2999(90)90670-2","article-title":"Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor.","volume":"184","author":"Lew","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.034702_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0165-6147(97)90663-5","article-title":"The dual nature of the tachykinin NK1 receptor.","volume":"18","author":"Maggi","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.102.034702_bib23","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1073\/pnas.85.9.3235","article-title":"Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease.","volume":"85","author":"Mantyh","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.034702_bib24","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/0016-5085(95)90394-1","article-title":"Differential expression of substance P receptors in patients with Crohn\u2019s disease and ulcerative colitis.","volume":"109","author":"Mantyh","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.102.034702_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-0115(01)00244-0","article-title":"Differential alterations in tachykinin NK2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation.","volume":"99","author":"Menzies","year":"2001","journal-title":"Reg Pept"},{"key":"10.1124\/jpet.102.034702_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2362.2001.00810.x","article-title":"Idiopathic chronic constipation: tachykinins as cotransmitters in colonic contraction.","volume":"31","author":"Mitolo-Chieppa","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/jpet.102.034702_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0143-4179(98)90015-4","article-title":"The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles.","volume":"32","author":"Quartara","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1124\/jpet.102.034702_bib28","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)64789-X","article-title":"Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine.","volume":"157","author":"Renzi","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.102.034702_bib29","first-page":"481","article-title":"Light- and electron microscopic studies of interstitial cells of Cajal and muscle cells at the submucosal border of human colon.","volume":"68","author":"Rumessen","year":"1993","journal-title":"Lab Invest"},{"key":"10.1124\/jpet.102.034702_bib30","first-page":"79","article-title":"Changes in tachykinin NK-2 receptors in colon circular muscle from patients with diverticular disease and ulcerative colitis (Abstract).","volume":"8","author":"Shang","year":"2000","journal-title":"Proc Aust Soc Clin Exp Pharmacol Toxicol"},{"key":"10.1124\/jpet.102.034702_bib31","first-page":"G987","article-title":"Defect in colonic smooth muscle contraction in patients with ulcerative colitis.","volume":"261","author":"Snape","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.102.034702_bib32","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/gast.2001.23251","article-title":"Immunohistochemical demonstration of the NK1 tachykinin receptor on muscle and epithelia in guinea pig intestine.","volume":"120","author":"Southwell","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.102.034702_bib33","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0016-5085(96)70057-4","article-title":"Interstitial cells of Cajal in human colon and in Hirschsprung\u2019s disease.","volume":"111","author":"Vanderwinden","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.102.034702_bib34","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bjp.0702648","article-title":"Characterization of the [I125]-neurokinin A binding site in the circular muscle of human colon.","volume":"127","author":"Warner","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.034702_bib35","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1440-1681.2000.03363.x","article-title":"Circular muscle contraction, messenger signalling and localization of binding sites for neurokinin A in human sigmoid colon.","volume":"27","author":"Warner","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/jpet.102.034702_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0016-5085(88)90287-9","article-title":"Distribution and co-existence of peptides in nerve fibers of the external muscle of the human gastrointestinal tract.","volume":"95","author":"Wattchow","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.102.034702_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0167-0115(99)00006-3","article-title":"Neurokinin B- and substance P-like immunoreactivity are co-localized in enteric nerves of rat ileum.","volume":"80","author":"Yunker","year":"1999","journal-title":"Regul Pept"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524358094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524358094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.034702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:24:19Z","timestamp":1740007459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524358094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0022356524358094"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.034702","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles of Substance P Receptors in Human Colon Circular Muscle: Alterations in Diverticular Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.034702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}